Pulmonx Stock Forecast
NASDAQ: LUNGHealthcareMedical DevicesUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
LUNG analyst consensus
Consensus (5 analysts)
none
Avg. price target
$3.40+87.85%
- Strong buy 0
- Buy 3
- Hold 2
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 5 Wall Street analysts covering Pulmonx (2026-10-09), 3 rate the stock a buy or strong buy, 2 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "none". The average 12-month price target is $3.40, with a high estimate of $5.00 and a low estimate of $2.50. The average target implies upside of 87.8% from the current price of $1.81.
The spread between the highest and lowest targets is 100.0%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for LUNG.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 3 | 60% |
| Hold | 2 | 40% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-09.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $2.50 | +38.12% |
| Average target | $3.40 | +87.85% |
| High target | $5.00 | +176.24% |